NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Overview Fund Activity
Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

13 hedge funds and large institutions have $47.9M invested in NKGen Biotech, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 13 closing their positions.

Holders
13
Holders Change
-12
Holders Change %
-48%
% of All Funds
0.21%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
1
Increased
3
Reduced
3
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MC
1
Meteora Capital
Florida
$17.6M
2
DC
2
Diametric Capital
Massachusetts
$3.91M
3
RCM
3
Rivernorth Capital Management
Florida
$6.01M
4
CS
4
Clear Street
New York
$609K

Top Sellers

1
RCM
1
Radcliffe Capital Management
Pennsylvania
$0
2
MF
2
Magnetar Financial
Illinois
$0
3
FTCM
3
Fir Tree Capital Management
New York
$0
4
UOC
4
UBS O'Connor
Illinois
$0
5
KL
5
KIM LLC
Kansas
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SSA
26
Schonfeld Strategic Advisors
New York
– – -11,085 Closed
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
1
2